Study title:
AN 00632998 Medline 20070101.
TI The effect of cyproheptadine and human growth hormone on adrenocortical function in children with hypopituitarism.
SO The Journal of pediatrics, {J-Pediatr}, Mar 1978, vol. 92, no. 3, p. 491-4, ISSN: 0022-3476.
AU Kenien-A-G, Zeidner-D-L, Pang-S-J, Becker-D-J, Postellon-D-C, Gutai- J-P, Foley-T-P-Jr, Drash-A-L. YR 1978.AN 00632998 Medline 20070101.
TI The effect of cyproheptadine and human growth hormone on adrenocortical function in children with hypopituitarism.
SO The Journal of pediatrics, {J-Pediatr}, Mar 1978, vol. 92, no. 3, p. 491-4, ISSN: 0022-3476.
AU Kenien-A-G, Zeidner-D-L, Pang-S-J, Becker-D-J, Postellon-D-C, Gutai- J-P, Foley-T-P-Jr, Drash-A-L. YR 1978.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Endocrine System Diseases [C19]
|
Brands: Please see report, Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: CYPROHEPTADINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|